COVID-19 Resources Hub

In this course you will learn about:
- Basic physiology of oxygen transport
- How pulse oximeters work
- How to use a pulse oximeter, including the Lifebox pulse oximeter
- Using a systematic approach to manage hypoxemia in severe acute respiratory infections (SARI)

By the end of this course, participants should be able to:

· Discuss appropriate use of lab tests and imaging for COVID-19 patients
· Explain rationale and list indications for oxygen therapy;
· Appropriately utilize pulse oximetry in evaluation & management of COVID19
· Classify a patient with COVID-19 as mild, moderate or severe & identify risk factors for progression
· Discuss considerations for home care
· Discuss indications for antimicrobial use in COVID-19 patients
· Recognize and manage common acute and chronic infections that may overlap with COVID-19

These guidelines are intended to help providers with the evaluation and treatment of severe cases of Covid-19 in children. Covid-19 and Multisystem inflammatory syndrome (MISC) in children have overlapping features. This resource helps to distinguish these two pathways.

85 potential therapeutic options are included within this database for COVID-19. This is the seventeenth edition and will continuously be updated as more research is released. The database is helpful for investigators, policy makers, and prescribers to ensure management of COVID-19 is based on the latest research.

These presentations and discussion are part of the COVID19 clinical updates webinars hosted by USAID’s Sustaining Technical and Analytic Resources and UCSF, with support from USAIDs O2 Ecosystem Initiative.

This webinar discusses Pulse oximetry - including the fundamentals of how it works, limitations in the technology (including skin pigmentation effects), and practical aspects of implementation including implications for oxygen consumption in resource-variable settings.

Red de Aprendizaje para la Respuesta a la COVID-19 en América Latina - Sesión el 3 de Marzo de 2021

Slide deck created Feb 2021 by the Partners In Health, US Public Health Accompaniment Unit

- Directrices de laboratorio
- Información y criterios para la priorización de pruebas diagnósticas
- Implementación de la prueba rápida de detección de antígenos para COVID-19
- Interpretación de resultados
- Nota Técnica: Caracterización genómica del SARS-CoV-2 y variantes circulantes en la Región de las Américas
- Orientaciones para la selección de muestras de SARS-CoV-2 para caracterización y vigilancia genómica

Note: this is a train the trainers course.

This self-guided reading was compiled (with input from multiple stakeholders) to enhance the quality of test results for detections of SARS-CoV-2, and is intended to support those setting up comprehensive quality assurance measures for COVID-19 testing laboratory networks.

Availability of different corticosteroids may vary. These tools demonstrate drug dosing conversions.

This searchable directory lists commercially available antigen RDTs and point-of-care molecular tests for COVID-19. Manufacturer performance data (sensitivity and specificity) are included, where known, alongside data from independent evaluations conducted by FIND, where applicable.

Learn how to plan for and establish COVID-19 testing in your laboratory to ensure accurate, timely and impactful results.

- L’état des lieux de la pandémie de COVID-19 et le rôle du diagnostic dans la riposte
- Les différents tests de diagnostic et leur utilisation dans le cadre de l’épidémie de COVID-19
- Les recommandations actuelles sur l’utilisation des tests de diagnostic de la COVID-19 et les stratégies de dépistage
- Les modalités de mise en place et de déploiement à grande échelle du diagnostic de la COVID-19, et les éléments essentiels pour garantir la sécurité, la qualité et l’impact des services de diagnostic